Kritische 8-K Meldungen
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (23.03.2026)
HOCH Abgang Schlüsselpersonen (23.03.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 23.03.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n Form 8-K is incorporated by reference into this Item 5.02. In accordance with the Merger Agreement, effective as of th |
| 16.06.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election |
| 29.04.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election |
| 06.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election |
| 03.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election |
| 25.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election |
| 01.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | t forth by specific reference in such filing. Item 5.02. Departure of Directors or Certain Officer |
| 12.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Form 8-K is incorporated herein by reference. Item 5.02 Departure of Directors or Certain Officer |
Stammdaten
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Unternehmen & Branche
| Name | EXACT SCIENCES CORP |
|---|---|
| Ticker | EXAS |
| CIK | 0001124140 |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
| SIC | 8071 · Services-Medical Laboratories |
Wertpapier & Kennzahlen
| CUSIP | 30054v104 |
|---|---|
| ISIN | US30054V1043 |
| Typ | COM |
| Marktkapitalisierung | 20,03 Mrd. USD |
| Beta | 1,44 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 3,246,990,000 | -207,949,000 | -1.10 | 5,860,629,000 | 2,401,052,000 |
| 2025-09-30 | 10-Q | 850,739,000 | -19,594,000 | -0.10 | 5,900,009,000 | 2,501,419,000 |
| 2025-06-30 | 10-Q | 811,085,000 | -1,185,000 | -0.01 | 5,797,365,000 | 2,469,414,000 |
| 2025-03-31 | 10-Q | 706,785,000 | -101,215,000 | -0.54 | 5,711,073,000 | 2,396,907,000 |
| 2024-12-31 | 10-K | 2,758,867,000 | -864,585,000 | -4.67 | 5,928,139,000 | 2,402,249,000 |
| 2024-09-30 | 10-K | -38,236,000 | -0.21 | |||
| 2024-09-30 | 10-Q | 708,655,000 | -38,236,000 | -0.21 | 6,748,571,000 | 3,210,511,000 |
| 2024-06-30 | 10-Q | 699,264,000 | -15,808,000 | -0.09 | 6,673,295,000 | 3,192,362,000 |
| 2024-06-30 | 10-K | -15,808,000 | -0.09 | |||
| 2024-03-31 | 10-Q | 637,524,000 | -110,228,000 | -0.60 | 6,376,321,000 | 3,132,618,000 |
| 2024-03-31 | 10-K | -110,228,000 | -0.60 | |||
| 2023-12-31 | 10-K | 2,499,766,000 | -49,766,000 | -0.27 | 6,471,334,000 | 3,145,305,000 |
| 2023-09-30 | 10-K | 794,000 | 0.00 | |||
| 2023-09-30 | 10-Q | 628,338,000 | 794,000 | 0.00 | 6,420,830,000 | 3,121,227,000 |
| 2023-06-30 | 10-K | -81,026,000 | -0.45 | |||
| 2023-06-30 | 10-Q | 622,093,000 | -81,026,000 | -0.45 | 6,355,563,000 | 3,056,622,000 |
| 2023-03-31 | 10-Q | 602,450,000 | -74,151,000 | -0.42 | 6,304,328,000 | 3,057,708,000 |
| 2023-03-31 | 10-K | -74,151,000 | -0.42 | |||
| 2022-12-31 | 10-K | 2,084,279,000 | -623,506,000 | -3.54 | 6,226,873,000 | 3,043,162,000 |
| 2022-09-30 | 10-Q | 523,073,000 | -148,761,000 | -0.84 | 6,306,566,000 | 3,108,634,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 17,415,415 | 0 | 17,415,415 | 1,768,709,548 | Neu | +100,0% | |
| BlackRock, Inc. | 29,574,118 | 0 | 29,574,118 | 1,551,952,958 | Neu | +100,0% | |
| Blackstone Inc. | 14,996 | 0 | 14,996 | 1,522,994,000 | Neu | +100,0% | |
| HBK INVESTMENTS L P | 7,646,637 | 0 | 7,646,637 | 776,592,454 | Neu | +100,0% | |
| STATE STREET CORP | 28,336,039 | 0 | 28,336,039 | 449,826,906 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 3,720,116 | 0 | 3,720,116 | 377,814,981 | Neu | +100,0% | |
| NORGES BANK | 3,430,733 | 0 | 3,430,733 | 348,425,243 | Neu | +100,0% | |
| MORGAN STANLEY | 13,913,329 | 0 | 13,913,329 | 341,033,312 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3,331,580 | 0 | 3,331,580 | 338,432,044 | Neu | +100,0% | |
| UBS Group AG | 3,172,007 | 0 | 3,172,007 | 309,483,977 | Neu | +100,0% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2,723,434 | 0 | 2,723,434 | 276,591,958 | Neu | +100,0% | |
| Beryl Capital Management LLC | 2,498,196 | 0 | 2,498,196 | 253,716,786 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 2,229,360 | 0 | 2,229,360 | 226,413,775 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 2,016,238 | 0 | 2,016,238 | 204,769,131 | Neu | +100,0% | |
| TUDOR INVESTMENT CORP ET AL | 1,987,828 | 0 | 1,987,828 | 201,883,812 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 1,717,958 | 0 | 1,717,958 | 174,476,168 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 1,676,305 | 0 | 1,676,305 | 170,245,536 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 1,603,705 | 0 | 1,603,705 | 162,874,759 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 1,591,656 | 0 | 1,591,656 | 161,648,583 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,532,235 | 0 | 1,532,235 | 155,613,787 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,517,454 | 0 | 1,517,454 | 154,112,628 | Neu | +100,0% | |
| FIL Ltd | 1,491,000 | 0 | 1,491,000 | 151,425,960 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 1,434,993 | 0 | 1,434,993 | 145,737,889 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1,429,459 | 0 | 1,429,459 | 145,175,856 | Neu | +100,0% | |
| Man Group plc | 45,352,093 | 0 | 45,352,093 | 144,343,777 | Neu | +100,0% | |
| Verition Fund Management LLC | 11,293,179 | 0 | 11,293,179 | 141,610,259 | Neu | +100,0% | |
| Champlain Investment Partners, LLC | 1,352,745 | 0 | 1,352,745 | 137,384,782 | Neu | +100,0% | |
| Weiss Asset Management LP | 129,000,000 | 0 | 129,000,000 | 134,691,946 | Neu | +100,0% | |
| LMR Partners LLP | 1,244,840 | 0 | 1,244,840 | 126,425,950 | Neu | +100,0% | |
| PERCEPTIVE ADVISORS LLC | 1,200,487 | 0 | 1,200,487 | 121,921,460 | Neu | +100,0% | |
| FMR LLC | 3,954,568 | 0 | 3,954,568 | 120,127,981 | Neu | +100,0% | |
| Hudson Bay Capital Management LP | 1,115,996 | 0 | 1,115,996 | 113,340,554 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 1,091,519 | 0 | 1,091,519 | 110,854,670 | Neu | +100,0% | |
| KRYGER CAPITAL Ltd | 1,009,312 | 0 | 1,009,312 | 102,505,727 | Neu | +100,0% | |
| Capital World Investors | 968,232 | 0 | 968,232 | 98,333,628 | Neu | +100,0% | |
| BAMCO INC /NY/ | 954,547 | 0 | 954,547 | 96,943,793 | Neu | +100,0% | |
| SOROS FUND MANAGEMENT LLC | 864,009 | 0 | 864,009 | 87,748,754 | Neu | +100,0% | |
| Squarepoint Ops LLC | 858,005 | 0 | 858,005 | 87,138,988 | Neu | +100,0% | |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 83,000,000 | 0 | 83,000,000 | 86,115,798 | Neu | +100,0% | |
| Walleye Trading LLC | 847,600 | 0 | 847,600 | 86,082,256 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 858,426 | 0 | 858,426 | 85,754,340 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 823,039 | 0 | 823,039 | 83,587,841 | Neu | +100,0% | |
| MACKENZIE FINANCIAL CORP | 812,115 | 0 | 812,115 | 82,591,711 | Neu | +100,0% | |
| Neuberger Berman Group LLC | 807,545 | 0 | 807,545 | 82,014,235 | Neu | +100,0% | |
| ALPINE ASSOCIATES MANAGEMENT INC. | 805,500 | 0 | 805,500 | 81,806,582 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 13,026,621 | 0 | 13,026,621 | 81,248,459 | Neu | +100,0% | |
| Polar Asset Management Partners Inc. | 25,112,000 | 0 | 25,112,000 | 78,847,688 | Neu | +100,0% | |
| CAPSTONE INVESTMENT ADVISORS, LLC | 49,191,384 | 0 | 49,191,384 | 76,731,587 | Neu | +100,0% | |
| Westchester Capital Management, LLC | 751,561 | 0 | 751,561 | 76,328,535 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 22,215,142 | 0 | 22,215,142 | 73,326,986 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-11-19 | Herriott James | Officer, SVP, General Counsel & Sec | Open Market Sale | -1,000 | 70.00 | -70,000.00 | -31,9% | |
| 2025-11-19 | ORVILLE JACOB A | Officer, EVP, GM, Screening | Open Market Sale | -5,000 | 75.00 | -375,000.00 | -171,0% | |
| 2025-11-04 | Baranick Brian | Officer, EVP, GM, Precision Oncology | Open Market Sale | -2,858 | 70.08 | -200,288.64 | -91,3% | |
| 2025-11-04 | Herriott James | Officer, SVP, General Counsel & Sec | Open Market Sale | -1,500 | 70.08 | -105,120.00 | -47,9% | |
| 2025-10-24 | Zanotti Katherine S | Director | Open Market Sale | -12,000 | 65.00 | -780,000.00 | -355,7% | |
| 2025-10-09 | Herriott James | Officer, SVP, General Counsel & Sec | Open Market Sale | -1,500 | 60.00 | -90,000.00 | -41,0% | |
| 2025-10-09 | Doyle James Edward | Director | Open Market Sale | -2,000 | 60.00 | -120,000.00 | -54,7% | |
| 2025-08-13 | Doyle James Edward | Director | Open Market Sale | -1,485 | 42.02 | -62,399.70 | -28,5% | |
| 2025-06-13 | Zanotti Katherine S | Director | Open Market Sale | -3,207 | 53.20 | -170,612.40 | -77,8% |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| VANGUARD GROUP INC | 17,415,415 | 1,768,709,548 | 11.07 |
| BlackRock, Inc. | 29,574,118 | 1,551,952,958 | 9.71 |
| Blackstone Inc. | 14,996 | 1,522,994,000 | 9.53 |
| HBK INVESTMENTS L P | 7,646,637 | 776,592,454 | 4.86 |
| STATE STREET CORP | 28,336,039 | 449,826,906 | 2.82 |
| MILLENNIUM MANAGEMENT LLC | 3,720,116 | 377,814,981 | 2.36 |
| NORGES BANK | 3,430,733 | 348,425,243 | 2.18 |
| MORGAN STANLEY | 13,913,329 | 341,033,312 | 2.13 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,331,580 | 338,432,044 | 2.12 |
| UBS Group AG | 3,172,007 | 309,483,977 | 1.94 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2,723,434 | 276,591,958 | 1.73 |
| Beryl Capital Management LLC | 2,498,196 | 253,716,786 | 1.59 |
| AQR CAPITAL MANAGEMENT LLC | 2,229,360 | 226,413,775 | 1.42 |
| Qube Research & Technologies Ltd | 2,016,238 | 204,769,131 | 1.28 |
| TUDOR INVESTMENT CORP ET AL | 1,987,828 | 201,883,812 | 1.26 |
| AMERIPRISE FINANCIAL INC | 1,717,958 | 174,476,168 | 1.09 |
| JANE STREET GROUP, LLC | 1,676,305 | 170,245,536 | 1.07 |
| DIMENSIONAL FUND ADVISORS LP | 1,603,705 | 162,874,759 | 1.02 |
| RENAISSANCE TECHNOLOGIES LLC | 1,591,656 | 161,648,583 | 1.01 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,532,235 | 155,613,787 | 0.97 |